Viewing nowCombinationTwo Tops Tablets 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.

MFDS item code 201605611 · Approved 2016.09.22 · Insurance code 642905750
Treatment of essential hypertension not controlled with telmisartan or amlodipine monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy using either telmisartan or amlodipine.
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. It is recommended, if possible, to take it at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as described below, a direct switch to this medication may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medication 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medication (a combination tablet containing the same amounts of each active ingredient) for convenience (limited to this medication 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients Requiring Caution'). In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
The safety and efficacy of this medication have not been established in pediatric patients aged 18 years and younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be stopped immediately if pregnancy is confirmed. This medication should not be administered to patients with certain conditions, such as those with severely impaired liver function, severe hypotension, pregnant women, breastfeeding mothers, and patients with specific heart diseases. Patients with impaired liver or kidney function, the elderly, and those with gastrointestinal diseases should be particularly cautious when taking this medication. Side effects such as dizziness or edema may occur while taking this medication, and in rare cases, serious side effects have been reported; if any unusual symptoms develop, consult a healthcare professional immediately. This medication can interact with other drugs, so if you are taking any other medications, you must inform your doctor or pharmacist. Women who are pregnant or planning to become pregnant should choose other treatments that have been confirmed safe instead, and breastfeeding women are advised not to take this medication. The safety and efficacy of this medication in children have not been sufficiently established, so it is not recommended for pediatric use. Elderly patients may require dosage adjustments and should be closely monitored while taking this medication. In case of overdose, hypotension, dizziness, and heart problems may occur, so it is important to adhere to the prescribed dosage and visit a healthcare facility immediately if an overdose is suspected. This medication should be kept out of reach of children and stored in its original packaging.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not permit light. Additionally, it should be stored at room temperature between 1 and 30 degrees Celsius.
This medicine is a double-coated oval-shaped tablet that is white and light blue on both sides.
30 tablets/box [10 tablets/Alu-Alu x3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.